Pro-Gastrin-Releasing Peptide (Pro-GRP) is a specific biomarker for SCLC, with a sensitivity of 60%-70% for early-stage SCLC; however, it has no diagnostic utility for NSCLC [17,18]. Here, GRP is linked to small cell lung carcinoma.